Shares of Palatin Technologies, Inc. (NYSEAMERICAN:PTN – Get Rating) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.27. Palatin Technologies shares last traded at $0.27, with a volume of 448,770 shares.
Palatin Technologies Stock Performance
The firm has a market capitalization of $61.40 million, a P/E ratio of -1.77 and a beta of 0.79.
Palatin Technologies (NYSEAMERICAN:PTN – Get Rating) last issued its quarterly earnings data on Tuesday, May 17th. The biopharmaceutical company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). The company had revenue of $0.22 million during the quarter, compared to analyst estimates of $0.58 million. During the same quarter in the prior year, the company posted ($0.02) earnings per share. As a group, research analysts forecast that Palatin Technologies, Inc. will post -0.13 EPS for the current year.
Institutional Investors Weigh In On Palatin Technologies
About Palatin Technologies
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
- Get a free copy of the StockNews.com research report on Palatin Technologies (PTN)
- Taking a Look at Nvidia’s Stock Amidst The Semiconductor Chip Gut
- Palantir Stock is Showing Signs of Life
- The Institutions Like The Color Of PPG Industries
- What Investors Need to Know to Beat the Market
- Alcoa Is Well-Positioned For 2022 and 2023
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.